<?xml version="1.0" encoding="UTF-8"?>
<ref id="B49" class="ref">
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Gaich</surname>
    <given-names class="given-names">G.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Chien</surname>
    <given-names class="given-names">J. Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Fu</surname>
    <given-names class="given-names">H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Glass</surname>
    <given-names class="given-names">L. C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Deeg</surname>
    <given-names class="given-names">M. A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Holland</surname>
    <given-names class="given-names">W. L.</given-names>
   </name>
   <etal class="etal"/>
  </person-group> (
  <year class="year">2013</year>). 
  <article-title class="article-title">The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes.</article-title>
  <source class="source">
   <italic class="italic">Cell Metab.</italic>
  </source>
  <volume class="volume">18</volume>
  <fpage class="fpage">333</fpage>â€“
  <lpage class="lpage">340</lpage>. 
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.cmet.2013.08.005</pub-id>
  <?supplied-pmid 24011069?>
  <pub-id pub-id-type="pmid" class="pub-id">24011069</pub-id>
 </mixed-citation>
</ref>
